Transmission of malignancy with solid organ transplants

Area of Science:

• Transplantation immunology
• Oncology
• Public health

Background:

• Donor-derived malignancy (DDM) is a rare but serious complication in organ transplantation, affecting 0.02-0.2% of recipients.
• The increasing use of older donors and expanded donor pools heightens the risk of tumor transmission.
• Understanding DDM is crucial for patient safety and optimizing organ allocation strategies.

Purpose of the Study:

• To review the current literature on tumor transmission via solid organ transplantation.
• To analyze the implications of expanding the donor pool, including donors with a history of cancer, on DDM risk.
• To propose evidence-based screening protocols for living and cadaveric donors to mitigate DDM.

Main Methods:

• Comprehensive literature search of peer-reviewed articles on tumor transmission in organ transplantation.
• Analysis of data on DDM incidence, risk factors, and outcomes.
• Synthesis of findings to develop recommendations for donor screening.

Main Results:

• DDM incidence is low but significant, with potential for increased risk in expanded donor pools.
• Certain cancers have a higher propensity for transmission than others.
• Current screening protocols may not fully address the risks associated with expanded donor criteria.

Conclusions:

• Proactive and refined donor screening is essential to minimize DDM risk.
• Implementing standardized screening regimens for all donors, irrespective of age or history, is recommended.
• Further research is needed to refine DDM risk assessment and prevention strategies.